XML 42 R31.htm IDEA: XBRL DOCUMENT v3.19.2
Segment Data (Tables)
6 Months Ended
Jun. 30, 2019
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment
The following tables reflects the segment recast for the prior-year period and reconciles Adjusted EBITDA for reportable segments to consolidated net income (loss):

 
 
At and For the Three Months Ended June 30, 2019
(In millions)
 
North America
 
Europe
 
APAC & Emerging Markets
 
Corporate
 
Eliminations
 
Total
Net sales
 
$
552

 
$
370

 
$
90

 
$

 
$
(3
)
 
$
1,009

Adjusted EBITDA
 
$
43

 
$
19

 
$
4

 
$
(13
)
 
$

 
$
53

Total assets
 
$
3,265

 
$
797

 
$
191

 
$
872

 
$
(935
)
 
$
4,190

 
 
 
 
 
 
 
 
 
 
 
 
 
Reconciliation of Net Loss Attributable to Covetrus to Adjusted EBITDA:
 
 
 
 
 
 
Net loss attributable to Covetrus
 
 
 
 
 
 
 
 
 
 
 
$
(10
)
Plus: Depreciation and amortization
 
 
 
 
 
 
 
 
 
 
 
41

Plus: Interest expense, net
 
 
 
 
 
 
 
 
 
 
 
14

Plus: Income tax expense
 
 
 
 
 
 
 
 
 
 
 
5

Earnings before interest, taxes, depreciation, and amortization
 
 
 
 
 
 
 
50

Plus: Share-based compensation
 
 
 
 
 
 
 
 
 
 
 
10

Plus: Formation of Covetrus
 
 
 
 
 
 
 
 
 
 
 
6

Plus: IT infrastructure
 
 
 
 
 
 
 
 
 
 
 
2

Plus: Other (income) expense items
 
 
 
 
 
 
 
 
 
 
 
(15
)
Adjusted EBITDA
 
 
 
 
 
 
 
 
 
 
 
$
53

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
At and For the Three Months Ended June 30, 2018
(In millions)
 
North America
 
Europe
 
APAC & Emerging Markets
 
Corporate
 
Eliminations
 
Total
Net sales
 
$
520

 
$
390

 
$
98

 
$

 
$
(3
)
 
$
1,005

Adjusted EBITDA
 
$
45

 
$
22

 
$
5

 
$
(10
)
 
$

 
$
62

Total assets
 
$
1,356

 
$
681

 
$
199

 
$
14

 
$
(4
)
 
$
2,246

 
 
 
 
 
 
 
 
 
 
 
 
 
Reconciliation of Net Income Attributable to Covetrus to Adjusted EBITDA:
 
 
 
 
 
 
Net income attributable to Covetrus
 
 
 
 
 
 
 
 
 
 
 
$
29

Plus: Depreciation and amortization
 
 
 
 
 
 
 
 
 
 
 
16

Plus: Interest expense, net
 
 
 
 
 
 
 
 
 
 
 
1

Plus: Income tax expense
 
 
 
 
 
 
 
 
 
 
 
8

Earnings before interest, taxes, depreciation, and amortization
 
 
 
 
 
 
 
54

Plus: Share-based compensation
 
 
 
 
 
 
 
 
 
 
 
2

Plus: Restructuring costs
 
 
 
 
 
 
 
 
 
 
 
6

Adjusted EBITDA
 
 
 
 
 
 
 
 
 
 
 
$
62


 
 
For the Six Months Ended June 30, 2019
(In millions)
 
North America
 
Europe
 
APAC & Emerging Markets
 
Corporate
 
Eliminations
 
Total
Net sales
 
$
1,049

 
$
731

 
$
176

 
$

 
$
(6
)
 
$
1,950

Adjusted EBITDA
 
$
78

 
$
35

 
$
8

 
$
(15
)
 
$

 
$
106

 
 
 
 
 
 
 
 
 
 
 
 
 
Reconciliation of Net Loss Attributable to Covetrus to Adjusted EBITDA:
 
 
 
 
 
 
Net loss attributable to Covetrus
 
 
 
 
 
 
 
 
 
 
 
$
(23
)
Plus: Depreciation and amortization
 
 
 
 
 
 
 
 
 
 
 
71

Plus: Interest expense, net
 
 
 
 
 
 
 
 
 
 
 
25

Plus: Income tax expense
 
 
 
 
 
 
 
 
 
 
 
1

Earnings before interest, taxes, depreciation, and amortization
 
 
 
 
 
 
 
74

Plus: Share-based compensation
 
 
 
 
 
 
 
 
 
 
 
25

Plus: Formation of Covetrus
 
 
 
 
 
 
 
 
 
 
 
15

Plus: Carve-out operating expenses
 
 
 
 
 
 
 
 
 
 
 
5

Plus: IT infrastructure
 
 
 
 
 
 
 
 
 
 
 
2

Plus: Other (income) expense items
 
 
 
 
 
 
 
 
 
 
 
(15
)
Adjusted EBITDA
 
 
 
 
 
 
 
 
 
 
 
106

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For the Six Months Ended June 30, 2018
(In millions)
 
North America
 
Europe
 
APAC & Emerging Markets
 
Corporate
 
Eliminations
 
Total
Net sales
 
$
1,001

 
$
761

 
$
196

 
$

 
$
(6
)
 
$
1,952

Adjusted EBITDA
 
$
79

 
$
39

 
$
10

 
$
(18
)
 
$

 
$
110

 
 
 
 
 
 
 
 
 
 
 
 
 
Reconciliation of Net Income Attributable to Covetrus to Adjusted EBITDA:
 
 
 
 
 
 
Net income attributable to Covetrus
 
 
 
 
 
 
 
 
 
 
 
$
51

Plus: Depreciation and amortization
 
 
 
 
 
 
 
 
 
 
 
33

Plus: Interest expense, net
 
 
 
 
 
 
 
 
 
 
 
1

Plus: Income tax expense
 
 
 
 
 
 
 
 
 
 
 
14

Earnings before interest, taxes, depreciation, and amortization
 
 
 
 
 
 
 
99

Plus: Share-based compensation
 
 
 
 
 
 
 
 
 
 
 
4

Plus: Restructuring costs
 
 
 
 
 
 
 
 
 
 
 
7

Adjusted EBITDA
 
 
 
 
 
 
 
 
 
 
 
$
110